Mpex Pharmaceuticals

Develops therapies for infectious diseases

placeSan Diego, California, United States calendar_todayFounded 2001 groups33 employees language mpexpharma.com

Registered entities

Innovation

20 patent families (10 granted) — focus: Human necessities, Chemistry & metallurgy, Emerging technologies; filing pace slowing. Cited 3,333 times.

YearFilings
20128
20138
20146
20154
20166
20173
20181
20191
20202
20212
20231

Investor mix

10 investors on record; lead investors include SV Health Investors, HBM Healthcare Investments, HBM Partners, Investor Growth Capital; 2 have since exited.

Investor typeCountShare
Venture capital660%
Private equity330%
Other / undisclosed110%
Coming soon